ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

Amit SenguptaSubscribe to Amit Sengupta

Votes against Trump Have Consolidated

While Hillary Clinton's campaign has received a boost in recent weeks because of the crass demeanour of her political opponent, there are stark similarities between the rise of Donald Trump in the US and Narendra Modi in India.

Votes against Trump Have Consolidated

While Hillary Clinton’s campaign has received a boost in recent weeks because of the crass demeanour of her political opponent, there are stark similarities between the rise of Donald Trump in the US and Narendra Modi in India.

Intellectual Property

[An open letter to Prime Minister Narendra Modi.] We, the undersigned, wish to share with you some of our concerns on India’s position on intellectual property (IP), particularly in the context of bilateral relations between the United States (US) and India. We gather from the US-India joint...

Two Decades of Struggle

The Supreme Court judgment in the Novartis case is important as it vindicates the entire process leading to health safeguards being incorporated in the Indian Patents Act. The article discusses this process, from the General Agreement on Tariffs and Trade and popular mobilisation in India to the enactment of and amendments to the Act, in the backdrop of the judgment.

Pharmaceutical Pricing Policy: A Critique

The recently announced draft National Pharmaceutical Pricing Policy 2011 fails to ensure accessible and affordable medicines for all in India. This is due to the limited scope and market-based approach it offers to price control. Among other measures, policy should fix ceiling prices based on lowest priced alternatives instead of high-priced top sellers, aim to revive pharmaceutical public sector undertakings, and expand the current National List of Essential Medicines. Most importantly, pharmaceuticals must be brought under the remit of the Ministry of Health and Family Welfare to allow better coordination for public health interests.

Takeover of Indian Pharma Companies

India is, today, the fourth largest producer of drugs in the world and a world class supplier of relatively cheap generic medicines. It is the largest supplier in the world of low-priced anti-retrovirals and exports medicines to over 200 countries. However, major concerns regarding access to...

Maoist and State Violence in Orissa - I

We strongly condemn the massacre of 13 policemen and two civilians in Nayagarh town of Orissa by armed Maoists on February 17. At the same time we also condemn, equally strongly, the subsequent killing of 35 alleged Maoists as claimed by the Orissa police. Going by past experience there are grave...

New Drug Policy-Prescription for Mortgaging Drug Industry

Once again the government has yielded to pressure from industry and moved towards easing control mechanisms for pharmaceuticals in the new drug policy. The impact of the policy on the production of drugs and their prices should be assessed against the background of the government's earlier moves to progressively minimise controls.
Back to Top